|
Butorov E.V.
HIV infection among the representatives of northern indigenous small-numbered peoples residing in the Surgut District of the Khanty-Mansi Autonomous Okrug – Yugra
|
№1 / 2018
|
|
Chernyavskaya O.A., Kozyrev O.A., Malyuzhenko I.V., Ioannidi E.A.
Clinical characteristics of HIV-infected patients in the Volgograd Region
|
№5 / 2017
|
|
Podymova A.S., Smirnova S.S., Gusev A.G., Kadyrov L.A., Posokhova L.A.
Sociomedical characteristics of persons in contact with hiv-infected patients
|
№4 / 2017
|
|
Voronin E.E., Afonina L.Yu., Orlova-Morozova E.A., Plotnikova Yu.K., Radzikhovskaya M.V.
The demographic and clinical characteristics of HIV-infected women in routine clinical practice in the Russian Federation: Results of a multicenter cross-sectional non-interventional study
|
№3 / 2017
|
|
Belyaeva V.V., Adigamov M.M.
Awareness about the modes of human immunodeficiency virus transmission and a stigmatizing attitude: Results of a survey of military-aged men
|
№3 / 2017
|
|
Sizova N.V., Korneeva T.S., Bratkova V.V., Sotnikova A.L., Rassokhin V.V.
Combined antiretroviral drugs containing lamivudine and zidovudine for the treatment of HIV infection
|
№1 / 2017
|
|
Ruziev M.M.
Specific features of the spread of HIV infection among persons who inject drugs in the Republic of Tajikistan
|
№1 / 2017
|
|
Belyaeva V.V., Adigamov M.M.
Prevention of human immunodeficiency virus infection: awareness, perceptions of individual risk of contamination, change in behavior
|
№6 / 2016
|
|
Ivanova E.S.
Phosphaside and lamivudine as a nucleoside base of first-line antiretroviral therapy regimens for HIV infection
|
№4 / 2016
|
|
Eremeeva Zh.G., Yakupova F.M., Turaev R.G., Fazylov V.Kh.
Infection safety of donor blood: Relevance of HBV testing
|
№4 / 2016
|
|
Belyaeva V.V., Adigamov M.M., Orlova M.O., Sokolova E.V.
Comparative analysis of the features of stigmatization of different social diseases
|
№4 / 2016
|
|
Kulabukhova E.I., Kravchenko A.V., Zimina V.N., Pokrovskaya A.V.
Genetic markers for HIV infection progression and secondary diseases development
|
№3 / 2016
|
Русский
